AKRON, Ohio, June 4, 2026 /PRNewswire/ -- Klutch Cannabis, one of the Midwest's premier vertically integrated cannabis companies, announced today that the Ohio Division...
CHARLOTTE, N.C., June 4, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the "Company") (Nasdaq: GRML) today announced that its Greenland operations team has...
ST. GALLEN, Switzerland and LONDON, June 04, 2026 (GLOBE NEWSWIRE) -- Sportradar Group AG (NASDAQ: SRAD), a leading global sports technology company creating immersive experiences for sports fans and bettors, today announced a multi-year extension of its data and audiovisual (AV) betting rights agreement for The Championships, Wimbledon. The rights were originally secured as part of the company’s acquisition of IMG ARENA in 2025.
This strategic initiative aligns with Danantara Indonesia's streamlining directive to TelkomGroup in strengthening its structure and sharpening its business focus.JAKARTA, Indonesia, June 4, 2026...
ZURICH, Switzerland – June 4, 2026 – gategroup, the global leader in airline catering, today announced it is continuing to pursue attractive opportunities in the market through the acquisition of 100% of LSG’s activities in Latvia and Estonia from Aurelius. This highly complementary transaction expands gategroup’s operational Nordics network into the Baltic region.
BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).
HighlightsFGR enters binding agreement to acquire all assets, intellectual property, product lines and manufacturing capabilities of USA-based MITO® Material Solutions, Inc.Strategic acquisition expands FGR's...
MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced the pricing of its upsized underwritten public offering of $500,000,000 aggregate principal amount of its 0.250% convertible senior notes due 2032 (the “Convertible Notes”). The aggregate principal amount of the offering was increased from the previously announced offering size of $400,000,000.
HighlightsFGR enters binding agreement to acquire all assets, intellectual property, product lines and manufacturing capabilities of USA-based MITO® Material Solutions, Inc.Strategic acquisition expands FGR's...
HighlightsFGR enters binding agreement to acquire all assets, intellectual property, product lines and manufacturing capabilities of USA-based MITO® Material Solutions, Inc.Strategic acquisition expands FGR's...